Clinical Trials Directory

Trials / Conditions / Recurrent Cervical Cancer

Recurrent Cervical Cancer

26 registered clinical trials studyying Recurrent Cervical Cancer — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy
NCT07418749
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3
Not Yet RecruitingQL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer
NCT07186868
Cancer Institute and Hospital, Chinese Academy of Medical Sciences—
Not Yet RecruitingThe Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC
NCT07172217
Qilu Hospital of Shandong UniversityPhase 2
RecruitingPD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With
NCT07472153
N.N. Alexandrov National Cancer CentrePhase 2 / Phase 3
RecruitingStudy on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer i
NCT06771193
MSD Italia S.r.l.—
UnknownFirst-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cance
NCT04974944
Sun Yat-sen UniversityPhase 2
CompletedA Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer
NCT04380805
AkesoPhase 2
TerminatedCabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
NCT04230954
University of South AlabamaPhase 2
CompletedStudy of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer
NCT04341883
Sun Yat-sen UniversityPhase 2
UnknownGenetic Mutation in Recurrent Cervical Cancer
NCT04191226
Lei Li—
CompletedCombination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer
NCT02849340
Fuda Cancer Hospital, GuangzhouPhase 1 / Phase 2
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
CompletedEribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
NCT01676818
University of Southern CaliforniaPhase 2
CompletedCarboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
NCT01652794
Case Comprehensive Cancer CenterPhase 1
CompletedStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
NCT01764789
Ohio State University Comprehensive Cancer CenterN/A
CompletedTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
University of Southern CaliforniaPhase 1
CompletedTriapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
NCT00941070
National Cancer Institute (NCI)Phase 2
CompletedStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan
NCT01079832
Case Comprehensive Cancer CenterPhase 2
CompletedSunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be
NCT00389974
National Cancer Institute (NCI)Phase 2
CompletedPhase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Witho
NCT00335998
National Cancer Institute (NCI)Phase 1
CompletedBevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
NCT00025233
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
NCT00031993
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00030498
National Cancer Institute (NCI)Phase 1
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1
WithdrawnColposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or
NCT01313104
Northwestern UniversityN/A